
Shanon A. Foley
Examiner (ID: 19153, Phone: (571)272-0898 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1619, 1642, 1648, 1671, 1645 |
| Total Applications | 1526 |
| Issued Applications | 841 |
| Pending Applications | 339 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17412787
[patent_doc_number] => 20220047691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Multivalent Virus Like Particle Vaccines
[patent_app_type] => utility
[patent_app_number] => 17/284614
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284614 | Multivalent virus like particle vaccines | Oct 16, 2019 | Issued |
Array
(
[id] => 17480665
[patent_doc_number] => 20220088169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => VIRUS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/285045
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285045 | VIRUS VACCINE | Oct 14, 2019 | Abandoned |
Array
(
[id] => 15435385
[patent_doc_number] => 20200031876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/600067
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/600067 | Porcine circovirus type 3 immunogenic compositions and methods of making and using the same | Oct 10, 2019 | Issued |
Array
(
[id] => 16367843
[patent_doc_number] => 10799578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Vaccine against porcine parvovirus
[patent_app_type] => utility
[patent_app_number] => 16/598110
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18814
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598110 | Vaccine against porcine parvovirus | Oct 9, 2019 | Issued |
Array
(
[id] => 17213147
[patent_doc_number] => 20210346483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Combination Vaccine Composition Comprising Reduced Dose Inactivated Poliovirus And Method For Preparing The Same
[patent_app_type] => utility
[patent_app_number] => 17/284529
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284529 | Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same | Oct 3, 2019 | Issued |
Array
(
[id] => 15405467
[patent_doc_number] => 20200023055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => Live-Attenuated Vaccine Having Mutations in Viral Polymerase for the Treatment and Prevention of Canine Influenza Virus
[patent_app_type] => utility
[patent_app_number] => 16/589247
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/589247 | Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus | Sep 30, 2019 | Issued |
Array
(
[id] => 17775044
[patent_doc_number] => 20220241393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/618625
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618625 | Porcine Reproductive and Respiratory Syndrome vaccine virus | Sep 26, 2019 | Issued |
Array
(
[id] => 16831032
[patent_doc_number] => 11007263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L
[patent_app_type] => utility
[patent_app_number] => 16/580058
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7473
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580058 | Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L | Sep 23, 2019 | Issued |
Array
(
[id] => 16604774
[patent_doc_number] => 10905758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Intranasal vector vaccine against porcine epidemic diarrhea
[patent_app_type] => utility
[patent_app_number] => 16/575121
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25861
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575121 | Intranasal vector vaccine against porcine epidemic diarrhea | Sep 17, 2019 | Issued |
Array
(
[id] => 17412790
[patent_doc_number] => 20220047694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => AFRICAN SWINE FEVER VIRUS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/276790
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276790 | African swine fever virus vaccine | Sep 17, 2019 | Issued |
Array
(
[id] => 15324755
[patent_doc_number] => 20200002707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => FUSION PROTEINS CONTAINING LUCIFERASE AND A POLYPEPTIDE OF INTEREST
[patent_app_type] => utility
[patent_app_number] => 16/571616
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/571616 | Fusion proteins containing luciferase and a polypeptide of interest | Sep 15, 2019 | Issued |
Array
(
[id] => 15619393
[patent_doc_number] => 20200080101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => EXPRESSION OF PEDV SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 16/566330
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/566330 | Expression of PEDV sequences in plants and plant produced vaccine for same | Sep 9, 2019 | Issued |
Array
(
[id] => 15740599
[patent_doc_number] => 20200109187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => NEUTRALIZING ANTI-INFLUENZA BINDING MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/560040
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16560040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/560040 | Neutralizing anti-influenza binding molecules and uses thereof | Sep 3, 2019 | Issued |
Array
(
[id] => 17045210
[patent_doc_number] => 11098379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Composition for detecting potato virus Y including M13KO7 bacteriophage and kit including the same
[patent_app_type] => utility
[patent_app_number] => 16/556791
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4206
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556791 | Composition for detecting potato virus Y including M13KO7 bacteriophage and kit including the same | Aug 29, 2019 | Issued |
Array
(
[id] => 15264863
[patent_doc_number] => 20190381165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Vaccines and Diagnostics for Novel Porcine Orthoreoviruses
[patent_app_type] => utility
[patent_app_number] => 16/557210
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557210 | Vaccines and Diagnostics for Novel Porcine Orthoreoviruses | Aug 29, 2019 | Abandoned |
Array
(
[id] => 20106984
[patent_doc_number] => 12357682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA
[patent_app_type] => utility
[patent_app_number] => 17/273258
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 22
[patent_no_of_words] => 18183
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273258 | DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA | Aug 29, 2019 | Issued |
Array
(
[id] => 17297929
[patent_doc_number] => 20210393768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/272199
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272199 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING VIRUS INFECTION | Aug 26, 2019 | Pending |
Array
(
[id] => 17286303
[patent_doc_number] => 11202841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Virus-enabled targeted vector for imaging
[patent_app_type] => utility
[patent_app_number] => 16/545301
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 7699
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16545301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/545301 | Virus-enabled targeted vector for imaging | Aug 19, 2019 | Issued |
Array
(
[id] => 17741478
[patent_doc_number] => 11389523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
[patent_app_type] => utility
[patent_app_number] => 16/545761
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 47
[patent_no_of_words] => 24894
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16545761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/545761 | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein | Aug 19, 2019 | Issued |
Array
(
[id] => 15324111
[patent_doc_number] => 20200002385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Virus-Like Particle
[patent_app_type] => utility
[patent_app_number] => 16/544060
[patent_app_country] => US
[patent_app_date] => 2019-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16544060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/544060 | Piscine myocarditis virus-like particles and methods of use thereof | Aug 18, 2019 | Issued |